Development of molecular subtype specific prognostic marker signature in immune response associated colon cancer through fuzzy based transcriptomic approach
View ORCID ProfileNecla Koçhan, View ORCID ProfileBarış Emre Dayanç
doi: https://doi.org/10.1101/2023.05.18.23290045
Necla Koçhan
1İzmir Biomedicine and Genome Center (IBG), 35340, İzmir, Turkey
Barış Emre Dayanç
2Basic Medical Sciences, Faculty of Medicine, Izmir University of Economics, Balcova, Izmir, Turkey
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted May 24, 2023.
Development of molecular subtype specific prognostic marker signature in immune response associated colon cancer through fuzzy based transcriptomic approach
Necla Koçhan, Barış Emre Dayanç
medRxiv 2023.05.18.23290045; doi: https://doi.org/10.1101/2023.05.18.23290045
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2909)
- Dermatology (249)
- Emergency Medicine (437)
- Epidemiology (12684)
- Forensic Medicine (10)
- Gastroenterology (824)
- Genetic and Genomic Medicine (4543)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2898)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (919)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4306)
- Nursing (233)
- Nutrition (633)
- Oncology (2251)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1192)
- Primary Care Research (492)
- Public and Global Health (6890)
- Radiology and Imaging (1518)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)